Chemoinformaics analysis of 9-Hydroxyjasmesoside
| Molecular Weight | 590.619 | nRot | 11 |
| Heavy Atom Molecular Weight | 548.283 | nRig | 20 |
| Exact Molecular Weight | 590.257 | nRing | 3 |
| Solubility: LogS | -1.311 | nHRing | 2 |
| Solubility: LogP | -0.146 | No. of Aliphatic Rings | 3 |
| Acid Count | 0 | No. of Aromatic Rings | 0 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 83 | No. of Aliphatic Hetero Cycles | 2 |
| No. of Heavy Atom | 41 | No. of Aromatic Carbocycles | 0 |
| nHetero | 14 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 1 |
| No. of Hydrogen atom | 42 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 27 | No. of Saturated Rings | 2 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
| No. of Oxygen atom | 14 | No. of Arom Bond | 0 |
| nHA | 14 | APOL | 84.3233 |
| nHD | 7 | BPOL | 52.5507 |
| QED | 0.102 |
| Synth | 5.475 |
| Natural Product Likeliness | 2.343 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Rejected |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Rejected |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.999 |
| HIA | 0.964 |
| CACO-2 | -5.984 |
| MDCK | 0.000281017 |
| BBB | 0.228 |
| PPB | 0.302417 |
| VDSS | 0.313 |
| FU | 0.273145 |
| CYP1A2-inh | 0.01 |
| CYP1A2-sub | 0.064 |
| CYP2c19-inh | 0.006 |
| CYP2c19-sub | 0.166 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.022 |
| CYP2d6-inh | 0.003 |
| CYP2d6-sub | 0.048 |
| CYP3a4-inh | 0.012 |
| CYP3a4-sub | 0.153 |
| CL | 1.633 |
| T12 | 0.862 |
| hERG | 0.025 |
| Ames | 0.436 |
| ROA | 0.11 |
| SkinSen | 0.159 |
| Carcinogencity | 0.868 |
| EI | 0.012 |
| Respiratory | 0.932 |
| NR-Aromatase | 0.03 |
| Antiviral | Yes |
| Prediction | 0.679215 |